1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
申请人:Bayer Pharma Aktiengesellschaft
公开号:US08101615B2
公开(公告)日:2012-01-24
The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
本发明涉及一种新型杂环衍生物,其一般式为(I),其制备过程以及其在药物中的应用,特别是用于治疗慢性阻塞性肺疾病、急性冠状动脉综合症、急性心肌梗死和心力衰竭的发展。